Mutations in genes of fusion essential proteins, OPA1 and Mfn2, have been associated with two neurodegenerative diseases, autosomal dominant optic atrophy (ADOA) [27], [28], [64]–[66] and CMT type 2A [67]–[70], respectively. Here, MFN2 is linked to autosomal dominant optic atrophy.